All In MedTech

FDA Clearance Tracker · P160054-S007

HeartMate 3™ Left Ventricular Assist System (LVAS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 5, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 5, 2018

Approved

Time to decision

80 days

Received Apr 16, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P160054-S007
Device name
HeartMate 3™ Left Ventricular Assist System (LVAS)
Applicant location
Pleasanton, CA
Received
Apr 16, 2018
Decided
Jul 5, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160054

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

Approval for introducing: 1) various design modifications to the Tunneling Adapter and Tunneling Lance; 2) various design modifications to the HeartMate 3 LVAD inner tray; and 3) a standalone packaging configuration for the modified Tunneling Adapter, with a shelf life of 3 years.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.